Abortion Charleston, WV 25311

ABORTION

Your first step in any bodily crisis is a medical consultation and diagnosis. Cross Roads offers free diagnostic services to help you through your abortion and pregnancy decisions.

Before deciding the outcome of your pregnancy, it is important to answer these three questions:

  1. Is my pregnancy viable?
    A positive pregnancy test does not mean that it will continue. 10 – 25% of all pregnancies end on their own, most often before 7 weeks. 1
  1. How far along am I?
    Gestational age determines the type and cost of abortion procedures that you could be eligible for. Only an ultrasound exam can accurately determine gestational age.
  2. Do I have an STD?
    Sexually Transmitted Diseases (STD’s) pose a serious risk to a woman’s future reproductive and overall health, especially if left untreated. According to the Centers for Disease Control, in the United States, 1 out of 4 women between the ages of 14 and 19 is infected with at least one STD. Any abortion procedure (including medical abortion) opens the risk of transmitting bacteria from outside the woman’s body or from the vagina into the woman’s cervix. Women who have an untreated STD (like chlamydia or gonorrhea) are up to 23% more likely to develop Pelvic Inflammatory Disease (PID) following an abortion procedure.2

Are you considering abortion?  Are you unsure of your options?  Here at Cross Roads we specialize in helping you through the process.  Our onsite medical professionals will answer your questions in a caring and confidential way.  We would be happy to serve you.

Contact us today:

Call 304-344-4511

Text 304-508-2911

contactus@crossroadspcc.com

Citations

National Institutes of Health (2014). Miscarriage. Retrieved from http://www.nlm.nih.gov/medlineplus/ency/article/001488.htm; Wilcox AJ, Weinberg CR, O’Connor JF, Baird DD, Schlatterer JP, Canfield RD (1988). Incidence of early loss of pregnancy. N Engl J Med; 319:89-94.)) (updated 9/25/2018)

Westergaard L, Phillipsen T, Scheibel J (1982). “Significance of cervical Chlamydia trachomatis infection in postabortal pelvic inflammatory disease.” Obstetrics and Gynecology, 68(5): 668-90; Ovigstad E, et al. (1983). “Pelvic inflammatory disease associated with Chlamydia trachomatis infection after therapeutic abortion.” Br J Vener Dis, 59: 189-92; Heisterberg L, et al. (1987). “The role of vaginal secretory immunoglobulin a, gardnerella vaginalis, anaerobes, and Chlamydia trachomatis in post abortal pelvic inflammatory disease.” Acta Obstetricia et Gynecologica Scandinavica, 66(2): 99-102.))